Table 5 Patterns of relapse of all patients who received h-R3/RT or CDDP/RT. (N = 104)
|  | h-R3/RT (N = 52) | CDDP/RT (N = 52) |
|---|---|---|
Relapse and metastasis | [n (%)] | [n (%)] |
Local recurrence | 2 (3.9%) | 2 (3.9%) |
Hepatic metastases | 2 (3.9%) | 3 (5.8%) |
Lung metastasis | 1 (1.9%) | 3 (5.8%) |
Bone metastasis | 1 (1.9%) | 2 (3.9%) |